• WELCOME TO
    AVANTGARDE UROLOGY
    Center of Minimally Invasive Surgery

Presentations in Greek Meetings

  • 3rd Annual Congress of the Association of General Surgeons of Northern Greece –Thessaloniki (1997)
    1.Ischemic intestinal disease .
    Exadactylos J., Makris T., Hatzikonstantinou N., Mpantounas D., Karamanolakis D., Gymnopoulos D.
    2. Hepatic trauma- Management of the hemorrhage with the application of compresses.
    Exadactylos J., Gymnopoulos D, Hatzikonstantinou N., Makris T., Mpantounas D., Karamanolakis D.
    3. Ileus-static analysis of 372 cases observed in 8 years.
    Gymnopoulos D,Exadactylos I., Hatzikonstantinou N., Mpantounas D., Makris T., Karamanolakis D.

  • 10th Pan Hellenic Congress of Hematology (Island of Rhodes, 1999)
    4. Study of D-dimers and of antithrombine III in patients with solid tumours before their treatment.
    K. Vallianatou, A. Athanasopoulos, D. Karamanolakis, O. Kesidou, K. Tsevdos,    
    M. Halili, A. Antonopoulou.

  • Monthly Meetings of the Hellenic Urologic Association – Amphitheatre of NIMTS (Athens)
    5. 15/12/99. Rare neoplasms of the bladder.
    K. Milathianakis, D. Petsis, D. Karamanolakis, H. Mpaliakos, A. Tsintavis.
    6. 15/11/00. Squamous carcinoma of the male urethra ( report of two cases)
    K. Milathianakis, D. Petsis, E. Mpitros, D. Karamanolakis, I. Mpogdanos, A. Tsintavis.
    7. 21/02/01. Report of two cases of carcinoma from germ cells.
    K. Milathianakis, I. Mpogdanos, D. Karamanolakis, I. Gavriel, A. Tsintavis.
    8. 20/06/01. Giant lipoma of the right adrenal as an incidental finding.
    K. Milathianakis, C. Farfarelos, D. Karamanolakis, I. Mpogdanos.
    9. 19/12/01. The drainage of the kidney after the pyeloplasty with a stent of multiple usefulness.
    A, Rigas, D. Karamanolakis, Ch. Mamoulakis, K. Mpratsas, A. Stefanidis, Ph. A. Androulakakis.
    10. 19/06/02. Insufficient secretion of ADH in a patient with hormone refractory prostate cancer.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, A. Tsintavis.
    11. 16/06/2004. Leiomyoma of the bladder.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, G. Vecchini, A. Tsintavis.

  • Monthly Meetings of the Hellenic Surgical Association – Amphitheatre of NIMTS (Athens)
    12. 18/12/01. Bilateral ureteric implantation under a common submucosal tunnel. Results of period 1982-2000.
    A. Androulakakis, A. Stefanidis, A. Rigas, D. Karamanolakis, H. Mamoulakis, K. Mpratsas.

  • 15th Pan Hellenic Urologic Congress – Corfu (September 2000)
    13. Prognostic value of PSA, prostate’s gland volume, tumour’s volume, and Gleason’s score in the adenocarcinoma of the prostate.
    K. Milathianakis, D. Petsis, D. Karamanolakis, I. Mpogdanos, E. Mpitros, A. Tsintavis.
    14. Relation between preoperative stage and histopathological findings in 110 patients with muscle invasive bladder carcinoma.
    K. Milathianakis, D. Petsis, D. Karamanolakis, E. Mpitros, I. Mpogdanos, A. Tsintavis.
    15. Relation between preoperative and postoperative findings in the prostate carcinoma (poster).
    K. Milathianakis, H. Mpaliakos, D. Petsis, E. Mpitros, I. Mpogdanos, D. Karamanolakis, A. Tsintavis.
    16. Penile carcinoma and lymphadenectomy. (poster)
    K. Milathianakis, D. Petsis, I. Mpogdanos, E. Mpitros, H. Mpaliakos, D. Karamanolakis, I. Vlachiotis, A. Tsintavis.
    17. Results of the intravescical infusions with BCG and Epirubicin (EP) in relation with monotherapy with EP or BCG in the superficial carcinoma of the bladder (poster).
    D. Petsis, K. Milathianakis, H. Mpaliakos, I. Mpogdanos, I. Gkialas, D. Karamanolakis, A. Tsintavis.
    18. Muscle invasive carcinoma of the bladder and necessity of bone scanning.
    K. Milathianakis, D. Petsis, D. Karamanolakis, I. Mpogdanos, E. Mpitros, A. Tsintavis.

  • Postgraduate Lessons of the Urologic Union of Piraeus
    19. 23/02/00. Lymphadenectomy in Urology.
    20. 07/02/01. Molecular biology of the urologic tumours.
    21. 06/02/02. Considerations in major urologic operations.

  • 10th Medical Congress of Crete – Island of Crete (2000)
    22. Comparative study for the diagnostic value between the cytologic examination of the urine sediment and the UBC Rapid test.
    K. Milathianakis, D. Petsis, I. Mpogdanos, D. Karamanolakis, A. Panousi, A. Alexiadou, E. Poulianou-Kyprioti.
    23. Locally advanced squamous cell carcinoma of the penis.
    K. Milathianakis, D. Petsis, I. Mpogdanos, D. Karamanolakis.

  • 10th Pan Hellenic Congress of Clinical Oncology – Athens (2001)
    24. UBC RAPID TEST and urothelium carcinoma.
    K. Milathianakis, I. Mpogdanos, D. Karamanolakis, I. Gavriel, A. Tsintavis.
    PUBLISHED ABSTRACT No: O31 to the VIMA OF CLINICAL ONCOLOGY Vol. 4 – Supplement 2001, pp: 126.

  • 27th Annual Pan Hellenic Medical Congress – Athens (May 2001)
    25. Clinical substaging of the adenocarcinoma of the prostate.
    K. Milathianakis, D. Karamanolakis, I. Mpogdanos, I. Gavriel, A. Tsintavis.
    26. Metastatic bone disease in the bladder carcinoma (poster).
    K. Milathianakis, D. Karamanolakis, I. Mpogdanos, I. Gavriil.
    27. The significance of the cytological examination of the urine sediment in the diagnosis of hematuria.
    K. Milathianakis, I. Mpogdanos, D. Karamanolakis, E. Mpitros, I. Gavriel, A.        
    Tsintavis.

  • Advances In Oncology. The expanding role of Octreotide. Noordwijk, Netherlands. (September 2001)
    28. Prostate cancer cell survival in bone metastasis and disease progression to androgen refractory stage: development of a novel endocrine manipulation for hormone refractory prostate cancer.
    Koutsilieris M., Mitsiades C., Sourla A., Sotiriou E., Tiblalexi D., Lembessis P., Dimopoulos T., Lambou T., Tsintavis A., Vacalikos J., Milathianakis C., Bogdanos J., Karamanolakis D., Kapsalis Z., Pliotas G., Dardoufas C.
    PUBLISHED ABSTRACT

  • 3rd Balkan Congress of Immunology – Athens (2001)
    29. Serum levels of EPO and TNFa in patients with prostate carcinoma and anemia, with lack of correlation between them.
    A. Chloraki-Mpompota, D. Karamanolakis, I. Mpogdanos, D. Lekakou, M. Paouri, K. Milathianakis, A. Tsintavis, E. Pagkalou-Thoua.

  • 12th Panhellenic Congress of Hematology – Athens (2001)
    30. Hematologic response and improvement of the quality of life, in patients with chronic anemia of the prostate cancer treated with recombinant human erythropoietin.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, A. Chloraki-Mpompota, M. Spyropoulou, D. Sirseloudis, P. Repousis, E. Pagkalou-Thoua, A. Tsintavis.
    PUBLISHED ABSTRACT: Haema Vol.4, No 5-Supplement (1) 2001, p 368.

  • 11th Panhellenic Congress of Oncology – Athens (2001)- Posters
    31. Prophylactic therapy with intravescical instillation of BCG-Epirubicin for superficial bladder cancer.
    K. Milathianakis, D. Karamanolakis, I. Mpogdanos, A. Panousi, G. Driva, A. Tsintavis.
    32. BTA-stat test in the benign affections of the urinary system.
    D. Karamanolakis, I. Mpogdanos, K. Milathianakis, A. Panousi, A. Alexiadou, E. Poulianou-Kyprioti, A. Tsintavis.
    33. Anemia during hormonal ablation therapy for prostate cancer.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, P. Repousis, D. Sirseloudis, G. Kourti, A. Chloraki-Mpompota, E. Paghalou-Thoua.
    34. Results from the use of Recombinant Human-B Epoetin in D3 stage prostate cancer patients with bone metastasis.
    I. Mpogdanos, D. Karamanolakis, D. Sirseloudis, G. Kourti, P. Repousis, A. Chloraki-Mpompota, E. Paghalou-Thoua, K. Milathianakis.
    35. Serum levels of EPO and TNFa in prostate cancer patients.
    D. Karamanolakis, A. Chloraki-Mpompota, I. Mpogdanos, K. Milathianakis, A. Tsintavis, E. Pagkalou-Thoua.
    36. Renal cell carcinoma and the synchronous retrieval of adrenal metastasis.
    D. Karamanolakis, I. Mpogdanos, K. Milathianakis, I. Gavriel, A. Tsintavis.
    37. Multifocality of renal cell carcinomas.
    K. Milathianakis, D. Karamanolakis, I. Mpogdanos, I. Gavriel, A. Tsintavis
    38. Comparative study of the cytological examination of the urine sediment and BTA-stat test.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, A. Panousi, A. Alexiadou, E. Poulianou-Kyprioti, A. Tsintavis.

  • 13th European Annual Meeting of Paediatric Urology - Budapest (April 2002)
    39. Ureteropelvic junction obstruction due to crossing renal vessels: clinical and  
    imaging features.
    A.Rigas, D. Karamanolakis, Ch. Mamoulakis, A. Stefanidis, P.A.  Androulakakis.
    PUBLISHED ABSTRACT in British Journal of Urology International,    
    official Journal of the ESPU.

  • 11th Panhellenic Congress of Clinical Oncology – Thessaloniki (April 2002)
    40. Comparative study between the cytologic examination of the urine speciment and the BTA-stat test for bladder cancer.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, S. Plyta, A. Pannoussi, A. Alexiadou, E. Poulianou-Kyprioti, A. Tsintavis.
    PUBLISHED ABSTRACT No: P 85 : VIMA OF CLINICAL ONCOLOGY, Vol. 5 - Supplement 2002, p 178.
    41. Treatment of the prostate cancer related anemia in patients with hormone refractory PCa and bone metastases using Epoetin-β.
    D. Karamanolakis, I. Mpogdanos, D. Syrseloudis, G. Kourti, P. Repoussis, A. Chloraki-Bobota, K. Milathianakis, H. Matzed, E. Paghalou-Thoua, A. Tsintavis.
    PUBLISHED ABSTRACT No: P 89: VIMA OF CLINICAL ONCOLOGY, Vol.5 - Supplement 2002, pp: 180.

  • 28th Annual Pan Hellenic Medical Congress – Athens (May 2001)
    42. The value of BTA-stat test in the evaluation of benign urologic diseases.
    D. Karamanolakis, I. Mpogdanos, K. Milathianakis, A. Pannoussi, S. Plita, A. Alexiadou, E. Poulianou-Kyprioti, A. Tsintavis.    
    43. Cytologic exam of the urinary sediment and BTA-stat test, in the evaluation of transitional cell carcinomas. Comparative study.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, A. Pannoussi, S. Plita, A. Alexiadou, E. Poulianou-Kyprioti, A. Tsintavis.
    44. Complete androgen deprivation and anemia at the adenocarcinoma of the patient.
    I. Mpogdanos, D. Karamanolakis, K. Milathianakis, P. Reppoussis, H. Matzed, M. Spyropoulou, D. Syrseloudis, G. Kourti.
    45. The use of Epoetin-B and reduction of blood transfusions in patients with advanced prostate carcinoma.
    I. Mpogdanos, D. Karamanolakis, D. Syrseloudis, G. Kourti, P. Repoussis A. Chloraki-Bobota, H. Matzed, E. Paghalou-Thoua, ,  K. Milathianakis, A. Tsintavis.
    46. External beam radiotherapy associated with complete androgen blockade to the locally advanced prostate carcinoma.
    M. Bouphy, M. Synodinou, K. Milathianakis, M. Hristodoulidou, I. Mpogdanos, D. Karamanolakis, A. Petridis, A. Menegakis.
    47. External beam radiation in locally advanced bladder cancer in elderly patients with the use of Aminofostine for cytoprotection.
    M. Bouphy, I. Mpogdanos, D. Karamanolakis, K. Milathianakis, M. Hristodoulidou, A. Menegakis, M. Synodinou-Menegaki, N. Throuvalas.

  • 21st Annual European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting (Prague, September 2002)
    48. Effect of Aminofostine on toxicities associated with radiation therapy for localized prostate cancer.
    M. Synodinou-Menegaki, D. Antonadou, M. Bouphy, D. Karamanolakis, N. Biazis, K. Papatheodorou, D. Nikolakis, K. Milathianakis, N. Trouvalas.
    PUBLISHED ABSTRACT, No: P , in the relative suppl. of Journal of   European Society of Radiology and Oncology, Vol. 64, Supplement 1, September 2002, p:. Official Journal of the ESTRO.
    49. Radiotherapy for elderly patients with locally advanced bladder cancer supported with aminofostine.
    M. Bouphy, M. Synodinou-Menegaki, D. Antonadou, I. Mpogdanos, D. Karamanolakis, K. Milathianakis, M. Hristodoulidou, G. Sarris, N. Throuvalas.
    PUBLISHED ABSTRACT, No: P 1046, in the relative suppl. of Journal of European Society of Radiology and Oncology, Vol. 64, Supplement 1, September 2002, pp: 306. Official Journal of the ESTRO.

  • 26th Congress of the Société Internationale d’Urologie – Stockholm (September 2002)
    50. Penile metastases of transitional cell carcinoma of the bladder presenting as priapism. Report of two cases [Moderated Poster. Published abstract].
    D.K. Karamanolakis, K.N. Milathianakis, I.M. Mpogdanos, I. Michailidis, G.D. Becchini, M. Synodinou.
    PUBLISHED ABSTRACT, No: MP-3.4.12, British Journal of Urology International Vol 90- Supplement 2, September 2002, p: 113. Official Journal of SIU.
    51. Anemia associated with Hormone Refractory Prostate Carcinoma. Effects of Recombinant Human ?-Epoietin [Moderated Poster. Published abstract].
    D.K. Karamanolakis, K.N. Milathianakis, I.M. Mpogdanos, P.B. Repousis, A. Chloraki-Bobota, H. Majed, E. Pagalou-Thoua, A.H. Tsintavis.
    PUBLISHED ABSTRACT, No: MP-5.1.10, British Journal of Urology International Vol 90- Supplement 2, September 2002, p: 181. Official Journal of SIU.

  • 16th Panhellenic Urologic Congress – Kalamata (September 2002)
    52. Radiotherapy in association with amifostine in bladder carcinoma (poster).
    M. Mpouphi, M. Hristodoulidou, D. Karamanolakis, I. Mpogdanos, K. Milathianakis, A. Menegakis, M. Synodinou-Menegaki, N. Throuvalas.
    53. Treatment of the BCG induced cystitis with the use of GM-CSF (poster). Milathianakis K, Mpogdanos J, Karamanolakis D.
    Proposed for Award.
    54. Results from the somministration of Zolendronic acid in the treatment of painful bony metastases in patients with hormone-refractory prostate cancer (oral presentation).
    Milathianakis K, Karamanolakis D, Mpogdanos J, Tsintavis A, Koutsilieris M.
    55. Influence of Complete Androgen Ablation in the bone density of patients with locally advanced prostate cancer (poster).
    Karamanolakis D, Mpogdanos J, Milathianakis K.
    56. The value of synchronous adrenalectomy in patients with renal cell carcinoma (poster).
    Mpogdanos J, Karamanolakis D, Milathianakis K, Tsintavis A.
    57. The value of Total Body In 111-Pentetreotide Nuclear Scan Examination in patients with hormone-refractory prostate cancer and osseous metastases (oral presentation).
    Mpogdanos J, Karamanolakis D, Milathianakis K, Tsintavis A, Limouris G, Koutsilieris M.
    58. The use of Recombinant Human Epoetin-? in patients with stage D3 prostate cancer and osseous metastases (poster).
    Mpogdanos J, Karamanolakis D, Milathianakis K, Repousis P, Chloraki-Mpompota A, Paghalou-Thoua E, Tsintavis A.
    59. Complete Androgen Ablation and anemia in patients with locally advanced prostate adenocarcinoma.
    Mpogdanos J, Karamanolakis D, Milathianakis K, Repousis P, Majed H, Tsintavis A.
    60. Multifocality in renal cell carcinoma (poster).
    Karamanolakis D, Milathianakis K, Mpogdanos J, Tsintavis A.
    Proposed for Award.
    61. Association of External Beam Radiation with Temporary Complete Androgen Ablation in the Locally Advanced Prostate Adenocarcinoma (poster).
    M. Mpouphi, Synodinou M, Milathianakis K, Karamanolakis D, Mpogdanos J, Menegakis A.
    62. Influence of the intravescical BCG therapy in the quality of life in patients with bladder carcinoma (Oral).
    Milathianakis K, Mpogdanos J, Karamanolakis D, Bafe E, Tsintavis A.
    63. Prognostic value of the positive intraprostatic surgical margins in radical prostatectomy specimens of organ confined prostate adenocarcinoma (poster).
    Milathianakis K, Mpogdanos J, Karamanolakis D, Vecchini GD, Tsintavis A, Arapantoni-Dadioti P.
    64. Prostate adenocarcinoma as incidental pathologic finding in radical cystectomy specimens for transitional cell carcinoma of the bladder.
    Milathianakis K, Karamanolakis D, Mpogdanos J, Vecchini GD, Tsintavis A, Arapantoni-Dadioti P.
    65. DNA analysis with flow cytometry of bladder tumours (oral presentation).
    Alexia S, Milathianakis K, Mpogdanos J, Karamanolakis D, Tsintavis A, Driva G.

  • European Association of Nuclear Medicine Annual Congress – Vienna (September 2002)
    66. How useful Octreoscan is in hormone-refractory prostate cancer patients with osseous metastases.
    M. Koutsilieris, K. Milathianakis, J. Bogdanos, D. Karamanolakis, A. Stavraka, G.S. Limouris.
    PUBLISHED ANSTRACT in European Journal of Nuclear Medicine and Molecular Imaging, Abstract No: P 198, Vol 29, Supplement 1, August 2002, p:240. Official Journal of the European Association of Nuclear Medicine.

  • 19th Panhellenic Congress of the Medical Division of the Hellenic Armed Forces-Thessaloniki (November 2002)
    67. Quality of life in patients with superficial bladder cancer under BCG treatment.
    K. Milathianakis, I. Bogdanos, DK. Karamanolakis, A. Tsintavis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed
    Forces (Abstract No: O 303) [www.iatrotek.org].
    68. Casually detected prostate adenocarcinoma in radical cystectomies’ specimens for invasive bladder carcinoma.
    K. Milathianakis, I. Bogdanos, DK. Karamanolakis, A. Tsintavis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces  (Abstract No: P 410) [www.iatrotek.org].
    69. The application of flowcytometric methods in the evaluation of transitional cell carcinoma tumors of the bladder.
    Alexia S, K. Milathianakis, I. Bogdanos, DK. Karamanolakis, A. Tsintavis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: P 411) [www.iatrotek.org].
    70. Treatment of BCG instillation induced hematuria with the intravescical somministration of GM-CSF growth factor.
    DK. Karamanolakis, I. Bogdanos, K. Milathianakis.
    PUBLISHED ABSTRACT in the Medical Review of the Hellenic Armed Forces (Abstract No: P 409) [www.iatrotek.org].
Attention! The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your physician for further evaluation.

Send your reply